Eli Lilly Wins U.K. Patent Suit on J&J Alzheimer’s Research
This article is for subscribers only.
Eli Lilly & Co. won a U.K. patent lawsuit against a Johnson & Johnson unit over a potential treatment for Alzheimer’s disease.
A patent held by J&J’s Janssen Alzheimer Immunotherapy Research & Development unit isn’t valid, Judge Richard Arnold said in a ruling in London today. Both companies are developing treatments targeting the build-up of plaque in patients’ brains that’s linked to the condition.